Kenvue, the consumer health subsidiary of Johnson & Johnson (J&J), has gone public after announcing plans of its “upsized” initial public offering (IPO) on the New York Stock Exchange (NYSE) last week. The firm’s common stock aimed to initially come in at 22 dollars per share under the symbol KVUE, however closed at 26.90 dollars after opening...
May 8, 2023
Johnson & Johnson will discontinue its talc-based baby powder globally in 2023 and transition to its existing cornstarch-based baby powder, following thousands of lawsuits over cancer claims. In a statement, Johnson & Johnson maintains that its product is safe to use, adding that it stands by decades of independent scientific analysis that shows...
Aug 15, 2022